menu Search
HIGHLIGHT
Riliz

Riliz Use In Pregnancy & Lactation

dienogest

Manufacturer:

BIOFEMME, Inc

Distributor:

UNILAB, Inc
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Use In Pregnancy & Lactation
Pregnancy: The administration of dienogest during pregnancy is contraindicated. If pregnancy occurs during treatment with dienogest, further intake must be stopped (see Contraindications).
The data from a limited number of cases of exposure during pregnancy demonstrate that dienogest does not show adverse effects on pregnancy or on the health of the fetus/newborn. No significant epidemiological data have been obtained to date. Animal studies reveal no special risks on pregnancy, embryonic/fetal development, birth, or development after birth for humans.
Dienogest must not be administered to pregnant women because there is no need to treat endometriosis during pregnancy.
Lactation: It is not known if dienogest is excreted in human milk. However, data have shown that dienogest is excreted into milk in rats. Dienogest is contraindicated during breastfeeding (see Contraindications).